Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'Preclinical Outsourcing'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 21, 2015
The company has invested €2 million in latest-generation technology to expand its R&D and quality control services Read More »
Published April 17, 2015
Takeover expands Sartorius’ service portfolio Read More »
Published April 9, 2015
Will provide Japanese
 clinical development services Read More »
Published April 7, 2015
Combined company to develop and market new services for pharmaceutical R&D Read More »
Published March 5, 2015
To provide integrated offering for candidate selection through to early stage trials Read More »
Using Technology to Improve Study Startup
By Roshan Padbidri and Maria Breaux , goBalto Singapore and goBalto San Francisco
Published January 29, 2015
A necessary step that provides companies with a competitive advantage. Read More »
Jump Starting the Non-Profit Research Engine
By Kate Hilyard , Managing Director, BioFocus
Published January 29, 2015
How CROs are teaming up with disease foundations to accelerate drug discovery. Read More »
What is Driving the Outsourcing Market?
By Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences
Published January 29, 2015
CRO industry generates healthy partnerships through co-development of drugs, diagnostics and demand for functional services. Read More »
Newsmakers: James Foster
By Kristin Brooks, Contract Pharma
Published May 1, 2014
Charles River Labs’ CEO James Foster is looking upstream to offer clients a faster “go/no go” indicator for preclinical work Read More »
By Gil Roth
Published November 13, 2013
Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis Read More »
By Gil Roth
Published November 13, 2013
Strong benefits in non-human primate studies Read More »
The Wild West of Basic Discovery
By Nancy Gillett, Charles River Laboratories
Published November 13, 2013
R&D outsourcing issues Read More »
By Kristin Brooks
Published November 6, 2013
Q&A with Ubavka DeNoble, M.D. about small and mid-size company needs Read More »
By Gil Roth
Published November 5, 2013
Triggers $15 mil. payment from Bayer Read More »
By Gil Roth
Published November 5, 2013
OMS721 cuts blood vessel development in half Read More »
By Gil Roth
Published November 1, 2013
Regen BioPharma signs clinical supply contract Read More »
Newsmakers: Biomarkers
By Gil Y. Roth, Contract Pharma
Published October 9, 2013
Vellalore Kakkanaiah of PPD on biomarker development Read More »
By Gil Roth
Published September 30, 2013
Phase I/II trial in type 2 reaches primary endpoints Read More »
By Gil Roth
Published September 26, 2013
Dompe, Exelixis, Lilly, Lumena, NovaRx, ProMetic, Sarepta, Read More »
By Gil Roth
Published September 26, 2013
PBI-4050 passes fox testing, safe to advance Read More »
By Gil Roth
Published September 17, 2013
Smith, Rayner named to help development Read More »
By Gil Roth
Published September 12, 2013
Pact covers nonclinical through registration Read More »
By Gil Roth
Published September 12, 2013
Italian research production facility to cover continent, UK Read More »
By Gil Roth
Published August 26, 2013
CEO David Spaight explains geographic, capacity play Read More »
By Kristin Brooks
Published August 21, 2013
Crown Bioscience's president talks about this preclinical play Read More »
Characterizing the Cost of Non-Clinical Development Activity
By Stella Stergiopoulos, Jennifer Kim, Kenneth Getz, Tufts CSDD
Published June 5, 2013
Understanding a critical R&D segment Read More »
Ensuring CV Safety
By Cyril Clarke, ICON Development Solutions
Published January 22, 2013
Integrated methodologies for early assessment Read More »
Cardio-Telemetry Q&A
By Gil Roth, Contract Pharma
Published January 22, 2013
A CRO talks about predicting potential cardiac events using telemetry-assisted studies Read More »
By Gil Roth
Published October 17, 2012
Three-year pact covers safety assessment, development DMPK Read More »
By Gil Roth
Published October 17, 2012
Paulson to lead clinical pharmacology, nonclinical development Read More »
By Gil Roth
Published October 17, 2012
Streamlined offering designed to support faster early phase decision making Read More »
By Gil Roth
Published October 16, 2012
Animal programs at facilities in WA, TX receive accreditation Read More »
By Gil Roth
Published August 28, 2012
Expands PDX drug discovery models in oncology Read More »
By Gil Roth
Published June 27, 2012
Plans to add 465 jobs as part of $150 million lab expansion Read More »
By Gil Roth
Published June 26, 2012
Will develop both KAHR-101 and KAHR-102 Read More »
By Gil Roth
Published June 25, 2012
Neviah Genomics to focus on toxicity biomarkers Read More »
By Gil Roth
Published June 21, 2012
Executive appointments follow sale to investors Read More »
By Gil Roth
Published June 5, 2012
Preclinical respiratory program triggers payment Read More »
Online Extra: Preclinical Perspectives
By Kristin Brooks, Contract Pharma
Published May 30, 2012
Providers look to a brighter future Read More »
Evolving Tactical Relationships Into Global Partnerships
By Andrew Townshend and Ian Lauf, MBA, INC Research and Boehringer-Ingelheim
Published May 30, 2012
Sponsor-CRO relationships in transition Read More »
CRO Outlook & Opportunities
By Kristin Brooks, Contract Pharma
Published May 30, 2012
e-Clinical solutions fuel advances Read More »
Newsmakers: Jim Mullen
By Gil Y. Roth, Contract Pharma
Published May 4, 2012
Patheon's CEO talks about his first year on the job Read More »
By Gil Roth
Published May 3, 2012
Preclinical revenues drop, offset by RMS uptick Read More »
By Gil Roth
Published May 3, 2012
Early Development slowdown leads to restructuring Read More »
By Gil Roth
Published April 23, 2012
Three-year program covers preclinical candidates Read More »
By Gil Roth
Published April 20, 2012
Will offer integrated "bench-to-bedside" services Read More »
By Steve Snyder, Contributing Editor
Published April 4, 2012
Time to say “goodbye” Read More »
By Gil Roth
Published April 4, 2012
Shaving cut with Occam’s Razor Read More »
Published March 8, 2012
Adds capabilities in North America and Europe Read More »
By Steve Snyder, Contributing Editor
Published March 7, 2012
Positive signs for CROs Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On